NYU Langone Health’s Perlmutter Cancer Center researchers have discovered a gene which drives the development of the second type of lung carcinoma.
This gives them greater insight into possible treatments.
Continue reading…
The development of the second most prevalent type of lung carcinoma is being driven by a newly identified gene
